Cite
HARVARD Citation
Thaçi, D. et al. (2020). Secukinumab is effective in treatment of moderate‐to‐severe plaque psoriasis: real‐life effectiveness and safety from the PROSPECT study. Journal of the European Academy of Dermatology and Venereology. pp. 310-318. [Online].